Cofe Fiakpui, LAc, utilizes a unique and highly effective method of diagnosing and treating patients with a wide variety of disorders many of whom have been to several other alternative medicine practitioners and doctors with little or no improvement.
This diagnostic technique, known as Acu-point Bio-photon Emissions Testing, was designed by Dr. Matt Van Benschoten and refined over a period twenty-five years of clinical trials. Cofe has been trained directly by Dr. Van Benschoten in this system, which integrates the acupuncture meridian system and herbal pharmacopia of the East with the bio-medical technological precision and sophistication of the West.
Cofe has achieved excellent results with patients who have had chronic, persistent ailments that were never completely resolved: chronic fatigue, recurrent sinusitis, respiratory conditions, allergies, and flus, lingering joint and back pain, dermatological issues, menstrual irregularities, recurrent yeast infections and candida overgrowth, hormonal imbalances and thyroid conditions, digestive disturbances, type II diabetes, and several other diseases. Utilizing the acu-point bio-photon diagnostic system, he is able to uncover the root cause of the patient’s condition and confirm the diagnosis with laboratory samples of every known pathogen in order to determine the specific type of bacteria, fungus, virus, toxin, or parasite at issue.
Once the diagnosis is made, the exact synergistic combination of pharmaceutical-grade Chinese herbal extracts is chosen from an extensive database of laboratory and clinical research. This personalized herbal formula is then tested on the patient using an apparatus designed to transmit the bio-photon energy of the herbs into the patient in order to test the efficacy of the formula to neutralize all the pathogenic bio-photon emissions in the patient’s acupuncture meridian system.
Unlike many other types of therapies, Cofe’s patients tend to experience marked results within 24 to 48 hours of taking the prescribed dosage of the personalized formula, often feeling immediate amelioration of their symptoms.
Vaccine Information
Before making the decision to be inoculated with the H1N1 vaccine either through nasal spray or injection, it is extremely important to become familiar with the risks, documented side effects, and dangers associated with this controversial vaccine.
The package insert for the Influenza A (H1N1) 2009 Monovalent Vaccine (Fluvirin) produced by Novartis, states that Fluvirin, based on their earlier flu vaccine, has been known to cause a long list of adverse effects including:
- Guillaume Barre Syndrome leading to paralysis
- Vasculitis
- Cardiovascular disorders
- Blood and lymphatic disorders
- Nervous system disorders
- Febrile convulsions
- Respiratory disorders
- Immune system disorders
- Hypersensitivity reactions leading to anaphylactic shock and even death.
This new vaccine has been rushed through the testing process in order to be available for the beginning of the 2009-2010 flu season and as a result has not been proven to be safe or effective.
Center for Disease Control (CDC) director, Dr. Thomas Frieden confirmed that the manufacturers of H1N1 vaccines have been given the green light to begin bottling experimental shots and readying them for shipment, even before Phase III test results were complete. Due to the 2006 Public Readiness and Emergency Preparedness Act (PREPA), vaccine manufacturers have been granted virtual immunity from lawsuits as well as permission to introduce supply-stretching toxic additives to vaccines such as mercury based thimerosal and squalene (linked to the Gulf War Syndrome), which have not been approved by the FDA.
.Squalene, one of the toxic additives in the H1N1 vaccine, has come under fire due to the evidence that links it to the Gulf War Syndrome, which soldiers developed after being inoculated with the anthrax vaccine containing squalene. Another toxic additive, thimerosal, which is used as a preservative, contains 25,000 times the amount of ethyl mercury that is considered safe and has been closely linked to autism and other neurological conditions
.Because of all of the known dangers associated with the H1N1 vaccine, the New York State healthcare workers upon being mandated to receive the vaccine have written a letter to the state government declaring, "We do not want to receive these vaccines. Our educated studies of risks versus benefits conclude that the risks of the vaccine are greater than the possible benefits."
These health-care workers are well aware of low effectiveness of influenza vaccines which is why they have found that the risks of vaccine complications far outweigh its influenza protective effect. A 2009 study in Current Topics Microbiology Immunology revealed that CDC officials have stated that the ability of flu vaccines to generate sufficient antibodies to effectively reduce symptoms and prevent death in influenza patients is only about 30 to 50 percent
.What about the nasal spray form of the swine flu vaccine? Isn´t that safer than the injection? Actually the nasal spray H1N1 vaccine contains a live H1N1 virus that although it has been weakened can still be shed from the nasal passages for up to 21 days. Therefore anyone who receives the H1N1 nasal spray vaccine can be spreading the virus to children under 2 years old or adults above 49 years old who are susceptible to the weakened live vaccine and could develop swine flu.
Cofe Fiakpui L.Ac. MATCM
For information about a safe and effective natural alternative to the H1N1 vaccine visit
Potent-Remedies.com 
